Pulmatrix Inc

NASDAQ:PULM   1:54:48 PM EDT
0.65
+0.05 (+7.60%)
Products

Pulmatrix Announces Resolution Of Contract Dispute With Cipla

Published: 11/09/2021 14:13 GMT
Pulmatrix Inc (PULM) - Pulmatrix Announces Resolution of Contract Dispute With Cipla.
Pulmatrix - Completed an Amendment to Pulmatrix's Agreement With Cipla Technologies for Development and Commercialization of Pulmazole.
Pulmatrix-completion of Amendment Resolves Co's Previously Disclosed Dispute With Cipla Regarding Continued Funding of Development Costs for Pulmazole.
Pulmatrix - Pursuant to 2nd Amendment Cipla Will Continue to Reimburse Co for 50% of All Third-party Costs for Development of Pulmazole.